Centro Hospitalar Universitario Lisboa Norte

Lisbon 1649-035

1 studies enrolling now · 3 studies all time

What they study most

FGFR 1 High Amplification, FGFR2 Amplification, Metastatic Breast Cancer, Metastatic Head and Neck Cancer, Primary Sclerosing Cholangitis, Recurrent Head and Neck Cancer, Unresectable Head and Neck Squamous Cell Carcinoma

Studies at this site

• A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 — Recruiting now
• A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. — Running, not enrolling
• A Study of TAS-120 in Patients With Metastatic Breast Cancer — Stopped early